Yahoo Finance • 3 days ago

Amgen (NASDAQ:AMGN) Has A Pretty Healthy Balance Sheet

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the permanent loss of capital.' So it seems the smart money knows that debt - which is usually involved in bankruptcies - is a ver... Full story

Yahoo Finance • 4 days ago

Bernstein SocGen lowers Amgen stock price target to $335 on MariTide risk

Investing.com - Bernstein SocGen Group lowered its price target on Amgen (NASDAQ:AMGN) to $335.00 from $350.00 on Thursday, while maintaining an Outperform rating on the stock. According to InvestingPro data, the stock currently trades at... Full story

Yahoo Finance • 5 days ago

Saudi Arabia Osteoporosis Drugs Market Analysis Report 2025-2033 Featuring Amgen, Eli Lilly and Co, F. Hoffmann La Roche, GlaxoSmithKline, Merck, Novartis, Pfizer, Teva Pharmaceutical, UCB

Dublin, Aug. 13, 2025 (GLOBE NEWSWIRE) -- The "Saudi Arabia Osteoporosis Drugs Market to Reach US$ 308.84 Million by 2033 - 4.33% CAGR Driven by Biologics and Aging Population" report has been added to ResearchAndMarkets.com's offering.... Full story

Yahoo Finance • 6 days ago

Vitiligo Treatment Strategic Market Research Report 2025-2030 | Increased Psychological and Social Impact of Vitiligo Drives Demand for More Effective Therapies

Dublin, Aug. 12, 2025 (GLOBE NEWSWIRE) -- The "Vitiligo Treatment - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global market for Vitiligo Treatment was estimated at US$1.5 Billion in 20... Full story

Yahoo Finance • 7 days ago

[Latest] Global High Flow Nasal Cannula Market Size/Share Worth USD 5.9 Billion by 2034 at a 5.4% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Austin, TX, USA, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “High Flow Nasal Cannula Market Size, Trends and Insights By Product Type (Single Heated Tube, Nasal Cannula, Active Hum... Full story

Yahoo Finance • 7 days ago

Chronic Inflammatory Demyelinating Polyneuropathy Market Report 2025 | Distribution Channel, Route of Administration, and Region Analysis and Forecast to 2035

Dublin, Aug. 11, 2025 (GLOBE NEWSWIRE) -- The "Chronic Inflammatory Demyelinating Polyneuropathy Market - A Global and Regional Analysis: Focus on Distribution Channel, Route of Administration, and Region - Analysis and Forecast, 2025-20... Full story

Yahoo Finance • 7 days ago

Gilead Sciences Is Closing In on an All-Time High. The Case for More Upside.

While Celgene was absorbed by Bristol Myers in early 2019, Gilead Sciences has emerged as the enduring standout among the remaining trio. Gilead has surged 59% and offers a healthy 2.6% dividend yield, while Amgen and Biogen have declined... Full story

Yahoo Finance • 10 days ago

SA Asks: How could Trump's drug pricing demands impact stocks?

[Pile of Prescription Pills and Bottles] Bjarte Rettedal Last week, President Trump sent letters to 17 major pharmaceutical companies advising them to work with his administration to lower drug prices within the next 60 days or face signi... Full story

Yahoo Finance • 10 days ago

Validea Detailed Fundamental Analysis - AMGN

Below is Validea's guru fundamental report for AMGEN, INC. (AMGN). Of the 22 guru strategies we follow, AMGN rates highest using our Multi-Factor Investor model based on the published strategy of Pim van Vliet. This multi-factor model see... Full story

Yahoo Finance • 10 days ago

Trump administration reportedly seeks higher ex-US drug prices in pursuit of MFN policy

[The White House in Washington DC] lucky-photographer The U.S. government has been discussing with drugmakers how to raise overseas drug prices as President Donald Trump seeks to implement his Most Favored Nation policy, which attempts to... Full story

Yahoo Finance • 11 days ago

Tokyo soars on trade deal relief as Asian markets limp into weekend

Investment giant soared more than 13 percent in Tokyo after posting healthy earnings (Kazuhiro NOGI) Japanese stocks rallied Friday on a mixed day for Asian markets, fuelled by relief that Tokyo and Washington had settled a tariff issue t... Full story

Yahoo Finance • 11 days ago

ProShares UltraPro QQQ Experiences Big Outflow

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the ProShares UltraPro QQQ (Symbol: TQQQ) where we have detected an approximate $143.4 million dollar outflow --... Full story

Yahoo Finance • 12 days ago

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.19%

Investing.com – U.S. stocks were higher after the close on Wednesday, as gains in the Consumer Services, Consumer Goods and Technology sectors led shares higher. At the close in NYSE, the Dow Jones Industrial Average rose 0.19%, while the... Full story

Yahoo Finance • 12 days ago

Stocks rebound on Apple boost as investors wade through quarterly earnings

[Wall Street sign with American flag in the background, symbolizing the financial heart of New York.] Wall Street's major averages largely rebounded on Wednesday, a day after closing in the red due to disappointing economic data. A rise i... Full story

Yahoo Finance • 12 days ago

Dow Movers: DIS, AAPL

In early trading on Wednesday, shares of Apple topped the list of the day's best performing Dow Jones Industrial Average components, trading up 2.7%. Year to date, Apple has lost about 16.8% of its value. And the worst performing Dow com... Full story

Yahoo Finance • 12 days ago

AMGEN INC (NASDAQ:AMGN) Shows Strong Technical Breakout Potential with High Setup Rating

Technical breakout strategies focus on spotting stocks with strong momentum that are moving within a narrow range, presenting a possible entry point before a potential upward move. This method uses two main indicators: the ChartMill Techni... Full story

Yahoo Finance • 12 days ago

Stock Market: Earnings Are Still Driving The Stock Futures

Today's economic calendar sees very few market-mover releases, which provide investors with a small amount of breathing room after a week of policy changes in monetary policy and mixed trade directions. But don't confuse this breathing roo... Full story

Yahoo Finance • 12 days ago

Amgen in charts: Key drug sales drop in Q2, but Otezla sees continued growth

[ ] Seeking Alpha   [ ] Seeking Alpha [ ] Seeking Alpha   [ ] Seeking Alpha [ ] Seeking Alpha     [ ] Seeking Alpha   MORE ON AMGEN * Amgen Inc. 2025 Q2 - Results - Earnings Call Presentation [https://seekingalpha.com/article/48... Full story

Yahoo Finance • 13 days ago

Amgen (AMGN) Q2 Profit Jumps 21%

Key Points Non-GAAP earnings per share for Q2 2025 beat estimates by 14.0%, rising to $6.02 (non-GAAP) and up 21% year over year (non-GAAP). Revenue increased 9% to $9.2 billion, exceeding analyst expectations for non-GAAP EPS and driven... Full story